Therapeutic Aspects of Carbon Monoxide in Cardiovascular Disease
AbstractCarbon monoxide (CO) is being increasingly recognized as a potential therapeutic with important signaling functions in various diseases. Carbon monoxide-releasing molecules (CORMs) show anti-apoptotic, anti-inflammatory, and anti-oxidant effects on the tissues of organisms, thus contributing to tissue homeostasis. An increase in reactive oxygen species production from the mitochondria after exposure to CO is also considered one of the underlying mechanisms of cardioprotection, although mitochondrial inhibition is the main toxic mechanism of CO poisoning. This review highlights the mechanism of the biological effects of CO and its potential application as a therapeutic in clinical settings, including in cardiovascular diseases. This review also discusses the obstacles and limitations of using exogenous CO or CORMs as a therapeutic option, with respect to acute CO poisoning. View Full-Text
Share & Cite This Article
Kim, H.-H.; Choi, S. Therapeutic Aspects of Carbon Monoxide in Cardiovascular Disease. Int. J. Mol. Sci. 2018, 19, 2381.
Kim H-H, Choi S. Therapeutic Aspects of Carbon Monoxide in Cardiovascular Disease. International Journal of Molecular Sciences. 2018; 19(8):2381.Chicago/Turabian Style
Kim, Hyuk-Hoon; Choi, Sangchun. 2018. "Therapeutic Aspects of Carbon Monoxide in Cardiovascular Disease." Int. J. Mol. Sci. 19, no. 8: 2381.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.